These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6537913)

  • 61. Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.
    Ebeling FC; Schmitt UM; Untch M; Nagel D; Fateh-Moghadam A; Stieber P; Seidel D
    Anticancer Res; 1999; 19(4A):2545-50. PubMed ID: 10470192
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tissue carcinoembryonic antigen in the prognosis of early invasive breast cancer.
    Hegg R; De Souza AZ; Pestana CB; Cardoso de Almeida PC
    Breast Cancer Res Treat; 1990 May; 15(3):213-6. PubMed ID: 2164851
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes.
    van der Linden JC; Baak JP; Postma T; Lindeman J; Meyer CJ
    J Clin Pathol; 1985 Nov; 38(11):1229-34. PubMed ID: 4066982
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer.
    Ikeda Y; Mori M; Kajiyama K; Kamakura T; Maehara Y; Haraguchi Y; Sugimachi K
    Hepatogastroenterology; 1996; 43(11):1281-7. PubMed ID: 8908563
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Serum levels of carcinoembryonic antigen (CEA) and pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast cancer].
    Kimoto A; Uemura K; Egami T; Kawaguchi H; Goto H; Miyauchi Y; Yokoyama I
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2022-8. PubMed ID: 7169574
    [No Abstract]   [Full Text] [Related]  

  • 66. Tumor markers in mammary carcinoma. An evaluation of carcinoembryonic antigen, placental alkaline phosphatase, pseudouridine and CA-50.
    Rasmuson T; Björk GR; Damber L; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
    Acta Oncol; 1987; 26(4):261-7. PubMed ID: 3479987
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Preliminary results of the analysis of the carcinoembryonic antigen (CEA) level in the serum of patients with dysplasias and benign neoplasms of the breast].
    Słuszniak J; Zagała A; Góźdź S; Bukowski J; Kowalski D; Korejba W; Banasińska E; Urbaniak A
    Nowotwory; 1986; 36(3):187-90. PubMed ID: 3822849
    [No Abstract]   [Full Text] [Related]  

  • 68. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].
    Mao YS; Zhang DC; Zhao XH; Wang LJ; Qi J; Li XX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of serum beta 2-microglobulin and carcinoembryonic antigen (CEA) in the follow-up of breast cancer patients.
    Staab HJ; Ahlemann LM; Anderer FA; Hiesche K; Rodatz W
    J Clin Chem Clin Biochem; 1981 Jun; 19(6):339-45. PubMed ID: 6168727
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunostaining for carcinoembryonic antigen does not discriminate for early recurrence in breast cancer. The ECOG experience.
    Gilchrist KW; Kalish L; Gould VE; Hirschl S; Imbriglia JE; Levy WM; Patchefsky AS; Pickren J; Roth JA; Schinella RA
    Cancer; 1985 Jul; 56(2):351-5. PubMed ID: 3891068
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA.
    Yuan SQ; Zhou ZW; Wan DS; Chen G; Lu ZH; Wang GQ; Pan ZZ
    Ai Zheng; 2008 Jun; 27(6):612-7. PubMed ID: 18570735
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Utility of a serum tumour marker panel in the post-operative follow-up of breast cancer patients with equivocal conventional radiological examinations.
    Nicolini A; Carpi A; Ferrari P; Pieri L
    Tumour Biol; 2003; 24(6):275-80. PubMed ID: 15004486
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
    Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
    Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Significance of serum concentrations of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer.
    Bezwoda W; Derman D; Bothwell T; MacPhil P; Levin J; De Moor N
    Cancer; 1981 Oct; 48(7):1623-8. PubMed ID: 7284963
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multivariate analysis of prognostic determinants for colorectal cancer patients with high preoperative serum CEA levels: prognostic value of postoperative serum CEA levels.
    Ma CJ; Hsieh JS; Wang WM; Su YC; Huang CJ; Huang TJ; Wang JY
    Kaohsiung J Med Sci; 2006 Dec; 22(12):604-9. PubMed ID: 17116621
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Carcinoembryonic antigen in cervical cancer: a five-year follow-up.
    Braun P; Leyendecker G
    Cancer Detect Prev; 1983; 6(1-2):249-53. PubMed ID: 6883384
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
    Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is there any clinical relevance of serial determinations of serum carcinoembryonic antigen in small cell lung cancer patients?
    Krischke W; Niederle N; Schütte J; Pfeiffer R; Hirche H
    Cancer; 1988 Oct; 62(7):1348-54. PubMed ID: 2843279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.